3.13
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Antares Pharma Inc | ATRS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 3.13 | 04:00:00 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 3.13 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.14 | 3.70 | 0.56 | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 3.13 | USD |
Antares Pharma Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 519.87M | 166.09M | 163.32M | $ 123.86M | $ 5.41M | - | 82.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 10.30% |
Antares Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATRS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.35 | 3.47 | 3.11 | 3.27 | 805,576 | -0.22 | -6.57% |
| 1 Month | 2.79 | 3.47 | 2.63 | 3.06 | 825,172 | 0.34 | 12.19% |
| 3 Months | 2.64 | 3.47 | 2.55 | 2.88 | 921,548 | 0.49 | 18.56% |
| 6 Months | 2.72 | 3.52 | 2.39 | 2.86 | 1,047,487 | 0.41 | 15.07% |
| 1 Year | 3.47 | 5.15 | 1.60 | 3.35 | 1,357,168 | -0.34 | -9.8% |
| 3 Years | 2.07 | 5.15 | 1.58 | 3.06 | 1,213,256 | 1.06 | 51.21% |
| 5 Years | 1.45 | 5.15 | 0.67 | 2.72 | 1,164,727 | 1.68 | 115.86% |
Antares Pharma Description
| Antares Pharma Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's products include OTREXUP, Elestrin, Gelnique, Makena, and others. |
